Financials

  • Market Capitalization 615.13 M
  • Employee 345
  • Founded N/A
  • CEO N/A
  • Website www.cerus.com
  • Headquarter Delaware, United States
  • FIGI BBG000HBVZX8
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-25.75
Price to sales ratio
1.68

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2757
TCMD
Tactile Systems Technology, Inc. - Common Stock
27.63 USD-4.86%-12.26%+4.19%+174.93%623.23 M USD
2794
CTKB
Cytek Biosciences, Inc. - Common Stock
4.62 USD+2.44%+1.32%+14.36%+37.50%596.64 M USD
2843
BWAY
BrainsWay Ltd - American Depositary Shares
14.41 USD+2.20%-3.81%-0.62%+17.35%564.38 M USD
2867
NPCE
Neuropace, Inc. - Common Stock
15.89 USD-7.18%-10.73%-0.06%+50.19%541.75 M USD

Frequently asked questions about Cerus Corporation - Common Stock

What is the Cerus Corporation - Common Stock stock price today?

The current price of Cerus Corporation - Common Stock (CERS) is 3.07. Over the past 24 hours, the stock has changed by -0.65%. Follow the CERS chart for real-time price dynamics.

What is the stock ticker of Cerus Corporation - Common Stock?

Cerus Corporation - Common Stock trades under the ticker CERS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cerus Corporation - Common Stock stock going up?

CERS has changed by -4.66% over the last week, +18.53% over the last month, and +108.84% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Cerus Corporation - Common Stock net income for the last quarter?

Cerus Corporation - Common Stock reported net income of -1.64 M for the last quarter. The previous quarter showed -2.18 M, which means net income changed by +24.91%.

How many employees does Cerus Corporation - Common Stock have?

As of the latest available data, Cerus Corporation - Common Stock has 345 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cerus Corporation - Common Stock EBITDA?

Cerus Corporation - Common Stock EBITDA is 19.63 M, and its EBITDA margin is 36.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cerus Corporation - Common Stock stock?

You can buy Cerus Corporation - Common Stock (CERS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cerus Corporation - Common Stock stock?

Investing in Cerus Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CERS chart and related analysis on metatrader.com as part of your research.

Cerus Corporation - Common Stock

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

News